medigraphic.com
Órgano oficial de la Sociedad Mexicana de Cirugía Dermatológica y Oncológica, AC

2012, Number 3

<< Back Next >>

Dermatología Cosmética, Médica y Quirúrgica 2012; 10 (3)

Pellagra: More than a medical chronicle to tell

Hajar ST, Moreno CG, Arenas R, Galván MIL

Language: Spanish
References: 41
Page: 191-197
PDF size: 429.63 Kb.


ABSTRACT

Since 1735, Pellagra has been known, as a medical condition caused by niacin deficiency. Throughout history, numerous epidemics associated to populations with a diet based mainly on maize, have been reported. Nowadays, isolated cases are still diagnosed.
It is described as the disease with the four D’s: dermatitis, diarrhea, dementia and death, although if adequate treatment is administered promptly, dementia and death can be avoided. Treatment is based on a balanced diet and the exogenous administration of niacin, nicotinic acid or nicotinamide.


REFERENCES

  1. Bourges, H. “La pelagra y la niacina”. Cuadernos de Nutricion IV. 1984; 7(1): 3-10.

  2. Kaliaperumal K, Devinder MT. “Pellagra and skin”. Int Jour Dermat. 2002; 41(8): 476-481.

  3. Colón-Cuesta F, Reyes-Hernández F, Pérez-Alcocer YM et al. “Pelagra, presentación de un caso y revisión bibliográfica”. Bol Clin Hosp Infant. 2007; 24(2): 98-103.

  4. Hegyi J, Schwartz RA, Hegyi V. “Pellagra: Dermatitis, dementia, and diarrhea”. Int J Dermatol. 2004; 43(1): 1-5.

  5. Elmeore, JG, Feinstein AR. “Joseph Goldberger: An unsung hero of American Clinical Epidemiology”. Ann Intern Med. 1994; 121: 372-375.

  6. Sebrell, HW. “History of pellagra”. Federation Proceedings. 1981; 40(5): 1520-1522.

  7. Fariña-Pérez LA. “Knowledge of the urogenital diseases in the work of Gaspar Casal, natural and medical history of the Principality of Asturias”. Arch Esp Urol. 2008; 60(8): 909-915.

  8. López-Piñero JM. “Gaspar Casal: descripción ecológica de la pelagra, primera enfermedad carencial”. Rev Esp Salud Pública. 2006: 411-415.

  9. Kumaravel R. “Pellagra in the United States: A historical perspective”. South Med J. Mar. 2000; 93(3): 272-277.

  10. Prousky JE. “Pellagra may be a rare secondary complication of anorexia nervosa: A systematic review of the literature”. Altern Med Rev. 2003; 180-185.

  11. Katz, SH, Hediger ML, Valleroy LA. “Traditional maize processing techniques in the New World”. Science. 1974; 184: 765-773.

  12. Carpenter KJ. “Effects of different methods of processing maize on its pellagragenic activity”. Federation Proceedings. 1981; 1531-1535.

  13. Paine RR, Brenton BP. “The paleopathology of pellagra: Investigating the impact of prehistoric and historical dietary transitions to maize”. Journal of Anthropological Sciences. 2006; 86: 125-135.

  14. Morabia A. “Joseph Goldberger’s research on the prevention of pellagra”. J R Soc Med. 2008; 101(11): 566-568.

  15. Evans, BK. “Joseph Goldberger: An unsung hero of american clinical epidemiology”. Ann Intern Med. 1994; 1(21): 372-375.

  16. Piqué-Durán, E, Pérez-Cejudo JA, Cameselle D, Palacios-Llopis S , García- Vázquez O. “Pellagra: A clinical, histopathological, and epidemiological study of 7 cases”. Actas Dermosifiliogr. 2012; 103(1): 51-58.

  17. Stratigos JD, Katsambas A. “Pellagra: A still existing disease”. Br J Dermatol. 1977; 99-106.

  18. Delgado-Sánchez L, Godkar D, Niranjan S. “Pellagra: Rekindling of an old flame”. Am J Ther. 2008; 15(2): 173-175.

  19. Arenas R. Dermatología. Atlas, diagnóstico y tratamiento. 4a ed., México, Mc Graw Hill, 2009: 579-582.

  20. Krehl WA. “Discovery of the effect of tryptophan on niacin deficiency”. Federation Proceedings. 1981: 1527-1530.

  21. Giugliano RP. “Niacin at 56 years of age-time for an early retirement?” New England Jounal of Medicine. 2011; 365: 2318-2320.

  22. Jagielska G, Tomaszewicz-Libudzic CE, Brzozowska A. “Pellagra: A rare complication of anorexia nervosa”. Eur Child Adolesc Psychiatry. 2007; 16: 417-420.

  23. Cleary MJ, Cleary JP. “Anorexia nervosa: A form of subclinical pellagra”. Int Clin Nutr Rev. 1989; 9: 137-143.

  24. Ladoyanni E, Cheung ST, North J, Tan Y. “Pellagra ocurring in a patient with atopic dermatitis and food allergy”. JEADV. 2006; 21: 394.

  25. Linares Torres, P, Casal Esteban V, Barbado Hernández FJ et al. “Encefalopatía pelagroide en el alcohólico crónico”. Emergencias. 1998; 10(4): 263-264.

  26. Soyun Ch, Jung-Chul Ch, Jee-Ho Ch, Kyung-Jeh S, Kee-Chan M, Jai-Kyoung K. “Wet pellagra”. International Journal of Dermatology. 2001; 539-544.

  27. Castiello RJ, Lynch PJ. “Pellagra and the carcinoid syndrome”. Arch Derm. 1972; 105: 574-577.

  28. Bilgili SG, Karadag AS, Calka O, Altun F. “Isoniazid-induced pellagra”. Cutan Ocul Toxicol. 2011; 30(4): 317-319.

  29. Garg G, Khopkar U. “Ethionamide-induced pellagroid dermatitis resembling lichen simplex chronicus: A report of two cases”. Indian J Dermatol Venereol Leprol. 2011; 77(4): 534.

  30. Oliveira A, Sanches M, Selores M. “Azathioprine-induced pellagra”. J Dermatol. 2011; 38(10): 1035-1037.

  31. Yokomizo, Y et al. “Two cases of pellagra associated with chemotherapy of docetaxel, estramustine, dexamethasone”. Hinyokika Kiyo. 2010; 56(10): 585-588.

  32. Ernst E. “Adverse effects of herbal drugs in dermatology”. British Journal of Dermatology. 2000; 143: 923-929.

  33. Murray MF. “Niacin as a potential AIDS preventive factor”. Med Hypothesis. 1999; 53: 375-379.

  34. Murray MF, Langan N, MacGregor RR. “Increased plasma triptophan in HIV-infected patients trated with pharmacologic doses of nicotinamide”. Nutrition. 2001; 17(7-8): 654-656.

  35. Shaun I. “The ‘gauntlet’ of pellagra”. Int J Derm. 1998; 37: 599.

  36. Williams AC, Hill LJ, Ramsden DV. “Nicotinamide, NAD(P)(H), and methyl-group homeostasis evolved and became a determinant of ageing diseases: Hypotheses and lessons from pellagra”. Curr Gerontol Geriatr Res. 2012 (en prensa).

  37. Wan P, Moat S, Anstey A. “Pellagra: A review with emphasis on photosensitivity”. Br J Dermatol. 2011; 164(6): 1188-1200.

  38. Brown, TM. “Pellagra: An old enemy of timeless importance”. Psycosomatics. 2010; 476-481.

  39. McKee PH, Calonje E, Brenn T, Lazar A. McKee’s pathology of the skin with clinical correlation. Vol. 2. 4a ed., Boston, Elsevier, 2011: 565-566.

  40. Weedon D. Skin Pathology. 3a ed., London, Churchill Livingstone Elsevier, 2009: 483-484.

  41. Barnhill R, Crowson AN, Magro C. Dermatopathology. 3a ed., Nueva York, McGraw-Hill, 2010: 76-77.




2020     |     www.medigraphic.com